BIPAP failure thresholds in severe COPD exacerbation — when do you intubate?
54M with known severe COPD, admitted with an infective exacerbation and type 2 respiratory failure. Started on NIV (BIPAP) with bronchodilators, steroids, and antibiotics. Two hours in: pH 7.28, pCO2 78, RR 30, still using accessory muscles, SpO2 92% on the current settings.
For those managing these on the ward/ICU boundary — what objective thresholds (pH trend, pCO2 trend, work of breathing, GCS) tip you from "continue NIV trial" to intubation, and how long is a fair NIV trial before it becomes dangerous delay?
1 Answer
The single most useful signal is the pH trend at 1-2 hours of a well-set NIV trial, not the absolute number. A pH that is static or falling despite good mask fit, adequate pressure support, and a cooperative patient is your cue to intubate. Rising pCO2 with a dropping GCS, worsening accessory-muscle use, or haemodynamic instability all lower my threshold. A reasonable NIV trial is ~1-2 hours with a clear plan — beyond that without improvement, continued NIV is usually just delay.